Medication delivery device

- Eli Lilly and Company
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front, bottom, right perspective view of a first embodiment of a medication delivery device, showing the new design in the first deployed configuration;

FIG. 2 is a front elevation view thereof;

FIG. 3 is a rear elevation view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is right side view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof;

FIG. 8 is a front, bottom, right perspective view thereof, showing the new design in the second deployed configuration;

FIG. 9 is a front elevation view thereof;

FIG. 10 is a rear elevation view thereof;

FIG. 11 is a left side view thereof;

FIG. 12 is right side view thereof;

FIG. 13 is a top plan view thereof;

FIG. 14 is a bottom plan view thereof;

FIG. 15 is a front, bottom, right perspective view of a second embodiment of a medication delivery device, showing the new design in the first deployed configuration;

FIG. 16 is a front elevation view thereof;

FIG. 17 is a rear elevation view thereof;

FIG. 18 is a left side view thereof;

FIG. 19 is right side view thereof;

FIG. 20 is a top plan view thereof;

FIG. 21 is a bottom plan view thereof;

FIG. 22 is a front, bottom, right perspective view thereof, showing the new design in the second deployed configuration;

FIG. 23 is a front elevation view thereof;

FIG. 24 is a rear elevation view thereof;

FIG. 25 is a left side view thereof;

FIG. 26 is right side view thereof;

FIG. 27 is a top plan view thereof;

FIG. 28 is a bottom plan view thereof;

FIG. 29 is a front, bottom, right perspective view of a third embodiment of a medication delivery device, showing the new design in the first deployed configuration;

FIG. 30 is a front elevation view thereof;

FIG. 31 is a rear elevation view thereof;

FIG. 32 is a left side view thereof;

FIG. 33 is right side view thereof;

FIG. 34 is a top plan view thereof; and,

FIG. 35 is a bottom plan view thereof.

The portions of the device shown in pale gray in FIGS. 15-28 are not intended to claim any specific color, but rather indicates visual contrast between the grayscale portion and other portions of the device.

The broken lines of even length illustrate portions of the medication delivery device and form no part of the claimed design.

Claims

The ornamental design for a medication delivery device, as shown and described.

Referenced Cited
U.S. Patent Documents
D462760 September 10, 2002 Ahlgrim
D492027 June 22, 2004 Tyce
D499485 December 7, 2004 Tyce
D501253 January 25, 2005 Bainton
D540465 April 10, 2007 Bainton
7291132 November 6, 2007 DeRuntz et al.
D600794 September 22, 2009 Tyce
7645264 January 12, 2010 Marsh
D610251 February 16, 2010 Tyce
D685464 July 2, 2013 Sanders
8663174 March 4, 2014 Zaiken
D703315 April 22, 2014 Sanders
D703810 April 29, 2014 Sanders
D716442 October 28, 2014 Magome
D717940 November 18, 2014 Magome
D725771 March 31, 2015 Sendatzki
D739011 September 15, 2015 Morrison, Jr. et al.
D743538 November 17, 2015 Sanders
D755369 May 3, 2016 Sanders
D770038 October 25, 2016 Ahlgrim et al.
D773646 December 6, 2016 Amend Kwasnik
D773650 December 6, 2016 Fourt et al.
D777907 January 31, 2017 Amend Kwasnik
D787047 May 16, 2017 Bainton
D799026 October 3, 2017 Jones
D832424 October 30, 2018 Shang et al.
D878562 March 17, 2020 Draper
D882764 April 28, 2020 Jones
D898900 October 13, 2020 Atterbury et al.
11071831 July 27, 2021 Bauer
D995762 August 15, 2023 Araia
D1034964 July 9, 2024 Jiang
D1051365 November 12, 2024 Araia
20110213311 September 1, 2011 Xu
20120041382 February 16, 2012 Chapin
20120041390 February 16, 2012 Spool
20120041417 February 16, 2012 Searle
20120302965 November 29, 2012 Cronenberg
20130274661 October 17, 2013 Teucher
20140213984 July 31, 2014 Pawar
20150025473 January 22, 2015 Banik
20170028141 February 2, 2017 Fiedler
20200206431 July 2, 2020 Antonelli
20200345945 November 5, 2020 Jugl
20220362477 November 17, 2022 Cohen
Foreign Patent Documents
305922804 July 2020 CN
015003050-0001 November 2022 EM
6243007 November 2022 GB
6243008 November 2022 GB
6243009 November 2022 GB
6243010 November 2022 GB
6243011 November 2022 GB
6243158 November 2022 GB
D1634236 June 2019 JP
D210009 February 2021 TW
Other references
  • Assignee website, lyumjev, Dec. 3, 2024, https://web.archive.org/web/20241203024558/https://insulins.lilly.com/lyumjev (Year: 2024).
  • “How to Use the Trulicity Pen for Type 2 Diabetes | Trulicity (dulaglutide),” www.trulicity.com/how-to-use. Accessed Jun. 10, 2022.
  • Linjawi, S., What Is Trulicity (Dulaglutide) And How Does It Work?, My Health Explained, accessed Jul. 14, 2023 at https://www.myhealthexplained.com/diabetes-information/diabetes-videos/trulicity-how-do-i-use-it-and-what-does-it-do, (published Sep. 28, 2021 as indicated by Wayback machine).
  • Tamble, Mounjaro Weight Loss Online Prescription, accessed Nov. 3, 2023 at https://www.weightlossmounjaro.net/mounjaro-weight-loss-online-prescription/.
Patent History
Patent number: D1147330
Type: Grant
Filed: Jan 22, 2024
Date of Patent: Sep 8, 2026
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Luke Andrew Gibson (Indianapolis, IN), Mitchell Ryan Hoge (Indianapolis, IN), Ross Merkel (Fishers, IN), Alex Joseph Pecoraro (Fishers, IN)
Primary Examiner: Nathan M Johnston
Application Number: 29/924,996